Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery
Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of ma...
Saved in:
Published in | Molecular pharmaceutics Vol. 6; no. 5; pp. 1417 - 1428 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
05.10.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 1543-8384 1543-8392 |
DOI | 10.1021/mp900083m |
Cover
Abstract | Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application. |
---|---|
AbstractList | Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application. Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application.Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application. |
Author | Häfeli, Urs O Dailey, James P Bardenstein, David Carmichael-Baranauskas, Anita Mark, Framin Riffle, Judy S Harris-Shekhawat, Linda |
Author_xml | – sequence: 1 givenname: Urs O surname: Häfeli fullname: Häfeli, Urs O email: uhafeli@interchange.ubc.ca – sequence: 2 givenname: Judy S surname: Riffle fullname: Riffle, Judy S – sequence: 3 givenname: Linda surname: Harris-Shekhawat fullname: Harris-Shekhawat, Linda – sequence: 4 givenname: Anita surname: Carmichael-Baranauskas fullname: Carmichael-Baranauskas, Anita – sequence: 5 givenname: Framin surname: Mark fullname: Mark, Framin – sequence: 6 givenname: James P surname: Dailey fullname: Dailey, James P – sequence: 7 givenname: David surname: Bardenstein fullname: Bardenstein, David |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19445482$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUlLxTAUhYMozgv_gGQj4uJpxrZZyntO4LBw2JbbNJVom9QkFd-_t_IcQARX9yy-c-Ccu4GWnXcGoR1KDilh9KjrFSGk4N0SWqdS8EnBFVv-1oVYQxsxPhHChGR8Fa1RJYQUBVtHD1PTtvi-T_BsMLgaW4cfbAoe3_k3q22aY9_gK3h0JlmNr8H5HsIoWxPx7WATVK3BjQ94FoZHPDOtfTVhvoVWGmij2f68m-j-9ORuej65vDm7mB5fToCLLE0YoxpqqmQuadVUXCilNLCaKMGaOtOsKDSlwHKQnCiSFVUuCFOgMp7lSlC-ifYXuX3wL4OJqexs1GMlcMYPscylkJKwsfW_JBckUxn9yNz9JIeqM3XZB9tBmJdfo43AwQLQwccYTPODkPLjIeX3Q0b26Bc7bgrJepcC2PZPx97CATqWT34IbhzwD-4dXlqWcw |
CitedBy_id | crossref_primary_10_3390_nano11092255 crossref_primary_10_1016_j_toxrep_2014_11_002 crossref_primary_10_1007_s13530_017_0299_z crossref_primary_10_3390_ijerph19138171 crossref_primary_10_1007_s10876_017_1256_3 crossref_primary_10_1007_s11051_011_0516_7 crossref_primary_10_1016_j_jconrel_2011_12_006 crossref_primary_10_1016_j_apsadv_2022_100303 crossref_primary_10_1016_j_jksus_2023_102689 crossref_primary_10_1002_biot_201100100 crossref_primary_10_1007_s11051_016_3455_5 crossref_primary_10_3390_nano10061018 crossref_primary_10_1016_j_cej_2015_04_152 crossref_primary_10_1021_nn300902w crossref_primary_10_1016_j_jhazmat_2015_10_041 crossref_primary_10_1155_2014_287575 crossref_primary_10_1007_s11051_013_1874_0 crossref_primary_10_1186_s11671_018_2457_x crossref_primary_10_1002_sia_4929 crossref_primary_10_1016_j_toxrep_2021_01_012 crossref_primary_10_1016_j_aquatox_2024_107218 crossref_primary_10_1039_c3ra40462e crossref_primary_10_1016_j_biomaterials_2010_04_062 crossref_primary_10_1016_j_jmmm_2014_10_041 crossref_primary_10_1186_1556_276X_7_210 crossref_primary_10_1155_2012_548389 crossref_primary_10_1002_jbm_a_34797 crossref_primary_10_1021_acs_inorgchem_6b03143 crossref_primary_10_1021_acs_jpcb_0c08089 crossref_primary_10_1088_0964_1726_25_1_015022 crossref_primary_10_1007_s11051_023_05716_3 crossref_primary_10_1021_ac9014534 crossref_primary_10_1007_s10529_019_02699_x crossref_primary_10_3109_02656736_2013_835876 crossref_primary_10_1021_acsbiomaterials_7b00839 crossref_primary_10_1016_j_jconrel_2017_04_003 crossref_primary_10_1080_17435390_2019_1650969 crossref_primary_10_1007_s10499_022_00870_2 crossref_primary_10_1016_j_ijbiomac_2019_10_272 crossref_primary_10_1021_jp109258f crossref_primary_10_1039_D0RA04220J crossref_primary_10_1016_S1734_1140_12_70901_5 crossref_primary_10_1186_s12951_021_01059_0 crossref_primary_10_1016_j_biomaterials_2016_06_007 crossref_primary_10_1016_j_lfs_2019_01_056 crossref_primary_10_3233_BSI_200205 crossref_primary_10_1016_j_nantod_2011_10_001 crossref_primary_10_4155_tde_11_48 crossref_primary_10_1016_j_etap_2013_07_005 crossref_primary_10_20535_ibb_2024_8_1_288067 crossref_primary_10_3390_cryst14080696 crossref_primary_10_1007_s00204_011_0773_3 crossref_primary_10_1007_s12668_024_01666_9 crossref_primary_10_3390_ijms12118288 crossref_primary_10_1002_app_37892 crossref_primary_10_1177_0748233720977383 crossref_primary_10_2174_0122117385277725231120043600 crossref_primary_10_3762_bjnano_12_22 crossref_primary_10_1016_j_colsurfb_2012_09_019 crossref_primary_10_2217_nnm_15_14 crossref_primary_10_1039_C3DT52377B crossref_primary_10_3390_pharmaceutics12020147 crossref_primary_10_1007_s13233_016_4034_4 crossref_primary_10_1039_C4CP05122J crossref_primary_10_1109_TMAG_2010_2046907 crossref_primary_10_1002_adhm_201300141 crossref_primary_10_3390_molecules25143159 crossref_primary_10_1016_j_ijpharm_2011_12_044 crossref_primary_10_1016_j_tiv_2017_07_022 crossref_primary_10_1109_TMAG_2012_2225024 crossref_primary_10_1166_jnn_2021_19062 crossref_primary_10_1021_la202470k crossref_primary_10_1088_0022_3727_43_41_415504 crossref_primary_10_2478_asn_2020_0014 crossref_primary_10_1016_j_jpcs_2015_09_008 crossref_primary_10_1039_C9SM02512J crossref_primary_10_1039_D2RA05216D crossref_primary_10_1021_cg400627c crossref_primary_10_1002_jbm_a_34011 crossref_primary_10_1016_j_jmmm_2015_04_030 crossref_primary_10_1016_j_jbiotec_2020_12_003 crossref_primary_10_4028_www_scientific_net_AMR_455_456_1221 crossref_primary_10_1007_s11095_011_0663_7 crossref_primary_10_1038_s41598_017_18665_4 crossref_primary_10_1039_D2TB01106A crossref_primary_10_3109_17435390_2015_1110759 crossref_primary_10_1016_j_cbi_2018_08_027 crossref_primary_10_1007_s11051_012_1151_7 crossref_primary_10_1021_la401891f crossref_primary_10_1016_j_saa_2017_03_056 crossref_primary_10_3390_polym3031243 crossref_primary_10_1016_j_jmmm_2010_02_019 crossref_primary_10_1007_s12035_024_04253_x crossref_primary_10_1021_mp100273t crossref_primary_10_1016_j_taap_2012_10_016 crossref_primary_10_1007_s10439_019_02393_z crossref_primary_10_1038_srep11129 crossref_primary_10_1016_j_nano_2016_08_027 crossref_primary_10_1039_C9NJ05989J crossref_primary_10_1007_s00396_014_3236_6 crossref_primary_10_3390_nano8050306 crossref_primary_10_1016_j_physe_2016_12_008 crossref_primary_10_1186_1556_276X_7_77 crossref_primary_10_1038_s41598_021_95195_0 crossref_primary_10_3389_fenrg_2020_00078 crossref_primary_10_3390_nano11102465 crossref_primary_10_1039_D2RA01139E crossref_primary_10_1093_toxsci_kfs300 crossref_primary_10_1007_s40139_021_00227_z crossref_primary_10_1016_j_mtchem_2021_100481 crossref_primary_10_1016_j_progpolymsci_2022_101574 crossref_primary_10_1007_s11814_016_0349_2 crossref_primary_10_1016_j_colsurfb_2017_10_048 crossref_primary_10_1007_s13273_012_0027_3 crossref_primary_10_1016_j_ijpharm_2021_120348 crossref_primary_10_2217_nnm_10_106 crossref_primary_10_1007_s11064_022_03798_4 crossref_primary_10_1007_s11434_013_6058_x crossref_primary_10_1039_c2nr32572a crossref_primary_10_1002_pat_4883 crossref_primary_10_1016_j_addr_2011_12_013 crossref_primary_10_1016_j_nano_2016_08_012 crossref_primary_10_1002_smll_201201531 crossref_primary_10_1021_acs_molpharmaceut_7b00109 crossref_primary_10_1002_ppsc_202000032 crossref_primary_10_1016_j_jmmm_2014_10_018 crossref_primary_10_1016_j_biomaterials_2010_07_087 crossref_primary_10_1039_C5NR01382H crossref_primary_10_3402_nano_v1i0_5358 crossref_primary_10_3390_polym14061188 crossref_primary_10_1515_znc_2017_0110 crossref_primary_10_3389_fbioe_2020_00822 crossref_primary_10_1016_j_cherd_2014_12_016 crossref_primary_10_1039_C8IB00038G crossref_primary_10_1088_1674_1056_22_2_027506 crossref_primary_10_1016_j_bbrep_2017_12_002 crossref_primary_10_1016_j_lfs_2021_119020 crossref_primary_10_3389_fbioe_2020_00144 crossref_primary_10_1007_s13139_020_00635_w crossref_primary_10_1002_wnan_1905 crossref_primary_10_1016_j_jmmm_2018_09_116 crossref_primary_10_3390_molecules21101357 crossref_primary_10_1016_j_ejpb_2016_12_024 crossref_primary_10_1186_s12951_016_0168_y crossref_primary_10_1517_17425247_2010_502560 crossref_primary_10_1186_s42833_019_0002_6 crossref_primary_10_1016_j_actbio_2011_09_013 crossref_primary_10_1002_tox_22098 crossref_primary_10_1557_jmr_2010_60 crossref_primary_10_15406_jnmr_2014_01_00004 crossref_primary_10_1016_j_jddst_2023_104295 crossref_primary_10_1155_2021_3762490 crossref_primary_10_1080_15287394_2022_2068711 crossref_primary_10_1186_1477_3155_8_25 crossref_primary_10_1063_1_4990790 crossref_primary_10_3390_molecules200916540 crossref_primary_10_1016_j_biopha_2018_09_106 crossref_primary_10_1039_C9NR08634J crossref_primary_10_1007_s11051_017_3800_3 crossref_primary_10_1142_S1793292023500765 crossref_primary_10_1109_TMAG_2012_2222635 crossref_primary_10_1088_1674_1056_22_12_127503 crossref_primary_10_1007_s40843_017_9049_0 crossref_primary_10_1016_j_carbpol_2011_11_033 crossref_primary_10_1016_j_onano_2023_100143 crossref_primary_10_1007_s11051_010_0019_y crossref_primary_10_1039_C5NR07144E crossref_primary_10_3390_nano11010173 crossref_primary_10_1098_rsfs_2016_0048 crossref_primary_10_1002_pi_3078 crossref_primary_10_1088_0957_0233_21_10_105803 crossref_primary_10_1186_s13578_015_0046_6 crossref_primary_10_1002_smll_201102525 crossref_primary_10_1016_j_msec_2019_110104 crossref_primary_10_1021_acsami_7b05741 crossref_primary_10_1016_j_jcis_2018_03_008 crossref_primary_10_1134_S1063774516010107 crossref_primary_10_4103_2348_0734_131792 crossref_primary_10_4155_tde_2022_0035 crossref_primary_10_1016_j_colsurfb_2014_02_034 crossref_primary_10_3389_fbioe_2020_00922 crossref_primary_10_3390_ijms150813967 crossref_primary_10_1186_1471_2202_13_32 crossref_primary_10_1007_s11706_020_0531_7 crossref_primary_10_1002_mabi_201100150 crossref_primary_10_1016_j_snb_2019_03_030 crossref_primary_10_1016_j_apsusc_2015_08_229 crossref_primary_10_1016_j_biomaterials_2010_08_010 crossref_primary_10_1089_jop_2012_0113 crossref_primary_10_3390_ijms241210072 crossref_primary_10_1103_PhysRevB_85_045435 |
Cites_doi | 10.1016/S0168-3659(01)00331-5 10.3109/10611869808997896 10.1039/b207789b 10.1038/74464 10.1517/14712598.3.5.745 10.1158/1078-0432.CCR-1004-0022 10.2310/7290.2006.00001 10.3233/JAD-2008-14211 10.1002/nbm.970 10.1158/1078-0432.CCR-06-0946 10.1016/0026-2862(84)90065-7 10.1586/17434440.3.4.427 10.1016/S0168-3659(98)00093-5 10.1002/pssb.200304692 10.1038/nbt1159 10.2214/ajr.152.1.167 10.1089/jam.2006.19.491 10.1016/j.jcis.2007.03.023 10.1038/nnano.2007.217 10.1102/1470-7330.2007.9001 10.1016/j.bbrc.2005.06.204 10.1076/orbi.22.1.15.14007 10.1016/S0304-8853(98)00584-8 10.1016/j.jacc.2006.06.069 10.1088/0953-8984/18/38/S24 10.1002/jgm.569 10.1093/toxsci/kfj027 10.1016/S0002-9394(14)77108-9 10.1021/la070116+ 10.3109/02652049609026013 10.1016/j.jmmm.2006.10.1170 10.1016/j.jcis.2008.09.071 10.1021/cm020994n 10.1007/s10544-007-9134-7 10.1016/j.jmmm.2005.02.037 10.1016/j.jmmm.2006.10.1174 10.1021/bc000091p 10.1016/S0304-8853(98)00560-5 10.1227/01.NEU.0000175731.25414.4c 10.1007/s003300100908 10.1002/jmri.21263 10.1016/S0142-9612(03)00348-X 10.1016/S1076-6332(98)80096-2 10.1248/bpb1978.3.264 10.1007/s002530051547 10.1038/nprot.2007.352 10.1016/j.acra.2004.04.018 10.1016/S0074-7696(08)62312-8 10.1038/bjc.1989.44 10.1016/S0022-1759(01)00433-1 10.1063/1.1850855 10.1016/S0075-7535(06)32007-4 10.1016/j.jmmm.2004.10.103 10.1593/neo.05769 10.1021/la0503451 10.1016/j.jmmm.2009.02.038 10.1002/bem.2250130710 10.2217/17435889.2.3.307 10.1088/0957-4484/14/6/318 10.1038/73219 |
ContentType | Journal Article |
Copyright | Copyright © 2009 American Chemical Society |
Copyright_xml | – notice: Copyright © 2009 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7QO 8FD FR3 P64 |
DOI | 10.1021/mp900083m |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE Engineering Research Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles |
EISSN | 1543-8392 |
EndPage | 1428 |
ExternalDocumentID | 19445482 10_1021_mp900083m d205466080 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 123 4.4 53G 55A 5VS 7~N AABXI ABMVS ABUCX ACGFS ACS AEESW AENEX AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CS3 DU5 EBS ED ED~ EJD F5P GNL H~9 IH9 JG JG~ LG6 P2P RNS ROL UI2 VF5 VG9 W1F X --- -~X AAYXX ABBLG ABJNI ABLBI ABQRX ADHLV AHGAQ CITATION CUPRZ GGK CGR CUY CVF ECM EIF IHE NPM 7X8 7QO 8FD FR3 P64 |
ID | FETCH-LOGICAL-a346t-221cad195751bfb34999ca2d0942fd6c288c11a27a5309068b74029a963679413 |
IEDL.DBID | ACS |
ISSN | 1543-8384 |
IngestDate | Fri Jul 11 16:20:30 EDT 2025 Thu Jul 10 18:20:51 EDT 2025 Mon Jul 21 05:33:55 EDT 2025 Tue Jul 01 04:33:28 EDT 2025 Thu Apr 24 23:02:23 EDT 2025 Thu Aug 27 13:42:20 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | phagocytosis polyethylene oxide (PEO) Toxicity confocal microscopy retinal pigment epithelial cells polyethylene glycole (PEG) magnetic nanoparticles MTT assay |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a346t-221cad195751bfb34999ca2d0942fd6c288c11a27a5309068b74029a963679413 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19445482 |
PQID | 734069611 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_754550252 proquest_miscellaneous_734069611 pubmed_primary_19445482 crossref_primary_10_1021_mp900083m crossref_citationtrail_10_1021_mp900083m acs_journals_10_1021_mp900083m |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N VG9 W1F ACS AEESW AFEFF ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-10-05 |
PublicationDateYYYYMMDD | 2009-10-05 |
PublicationDate_xml | – month: 10 year: 2009 text: 2009-10-05 day: 05 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Molecular pharmaceutics |
PublicationTitleAlternate | Mol. Pharmaceutics |
PublicationYear | 2009 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | Mulder W. J. (ref3/cit3) 2007; 2 Pislaru S. V. (ref16/cit16) 2006; 48 Arbab A. S. (ref61/cit61) 2006; 3 Plank C. (ref26/cit26) 2003; 3 Jordan A. (ref65/cit65) 1997; 74 Goodwin S. (ref11/cit11) 1999; 194 Harris L. A. (ref45/cit45) 2003; 15 Morana G. (ref4/cit4) 2007; 7 Jurgons R. (ref21/cit21) 2006; 18 Peters K. (ref74/cit74) 2004; 15 Morishita N. (ref28/cit28) 2005; 334 Dodd C. H. (ref68/cit68) 2001; 256 ref52/cit52 Sun H. (ref38/cit38) 2008; 10 Kim J. S. (ref60/cit60) 2006; 89 Lewin M. (ref6/cit6) 2000; 18 ref34/cit34 Schüler D. (ref55/cit55) 1999; 52 Häfeli U. O. (ref73/cit73) 1999; 194 Zhang Q. (ref46/cit46) 2007; 23 Collingwood J. F. (ref57/cit57) 2008; 14 Morimoto Y. (ref13/cit13) 1980; 3 Morales M. A. (ref36/cit36) 2005; 97 Park S. I. (ref37/cit37) 2004; 241 Wang Y. X. (ref1/cit1) 2001; 11 Mefford O. T. (ref25/cit25) 2007; 311 Choi H. (ref63/cit63) 2004; 11 Barrera C. (ref40/cit40) 2009; 329 Häfeli U. O. (ref9/cit9) 2006 Sako M. (ref10/cit10) 1985; 29 Clement O. (ref48/cit48) 1998; 5 Andrä W. (ref5/cit5) 2007 Bullok K. E. (ref70/cit70) 2006; 5 Lobel D. (ref22/cit22) 1978; 85 Asmatulu R. (ref24/cit24) 2005; 292 Holligan D. L. (ref23/cit23) 2003; 14 Gref R. (ref44/cit44) 2003 Barbon J. J. (ref51/cit51) 2007; 82 Häfeli U. O. (ref75/cit75) 2007 DeNardo S. J. (ref20/cit20) 2005; 11 Kohler N. (ref67/cit67) 2005; 21 Pulfer S. K. (ref17/cit17) 1998; 6 Kraitchman D. L. (ref7/cit7) 2008; 27 Hu F. (ref42/cit42) 2007; 311 Pieters R. (ref53/cit53) 1989; 59 Zange R. (ref72/cit72) 1998; 56 Dames P. (ref15/cit15) 2007; 2 Chouly C. (ref59/cit59) 1996; 13 Zhao H. (ref39/cit39) 2009; 321 Ally J. (ref14/cit14) 2006; 19 Gref R. (ref64/cit64) 2003; 24 Weissleder R. (ref32/cit32) 1989; 152 Liu X. Q. (ref41/cit41) 2007; 311 Weissleder R. (ref49/cit49) 2001; 12 Arbab A. S. (ref62/cit62) 2005; 18 Reddy G. R. (ref18/cit18) 2006; 12 Meyers P. H. (ref47/cit47) 1963; 90 Mykhaylyk O. (ref27/cit27) 2007; 2 Muldoon L. L. (ref58/cit58) 2005; 57 ref12/cit12 Wyllie A. H. (ref54/cit54) 1980; 68 Kirschvink J. L. (ref56/cit56) 1992; 1 Weissleder R. (ref66/cit66) 2005; 23 Mykhaylyk O. (ref30/cit30) 2008; 10 Tiefenauer L. X. (ref2/cit2) 2007 Bacon B. R. (ref31/cit31) 1987; 110 Schwalbe M. (ref71/cit71) 2005; 293 Holland D. (ref50/cit50) 2003; 22 ref33/cit33 Hyeon T. (ref35/cit35) 2003; 8 Montet X. (ref69/cit69) 2006; 8 Weissleder R. (ref8/cit8) 2000; 6 Gersting S. W. (ref29/cit29) 2004; 6 Greenwald R. B. (ref43/cit43) 2001; 74 Driscoll C. F. (ref19/cit19) 1984; 27 |
References_xml | – volume: 10 start-page: 493 year: 2008 ident: ref30/cit30 publication-title: Curr. Opin. Mol. Ther. – volume: 74 start-page: 159 year: 2001 ident: ref43/cit43 publication-title: J. Controlled Release doi: 10.1016/S0168-3659(01)00331-5 – volume: 6 start-page: 215 year: 1998 ident: ref17/cit17 publication-title: J. Drug Targeting doi: 10.3109/10611869808997896 – volume: 8 start-page: 927 year: 2003 ident: ref35/cit35 publication-title: Chem. Commun. doi: 10.1039/b207789b – volume: 18 start-page: 410 year: 2000 ident: ref6/cit6 publication-title: Nat. Biotechnol. doi: 10.1038/74464 – volume: 3 start-page: 745 year: 2003 ident: ref26/cit26 publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.3.5.745 – volume: 11 start-page: 7087s year: 2005 ident: ref20/cit20 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-1004-0022 – volume: 5 start-page: 1 year: 2006 ident: ref70/cit70 publication-title: Mol. Imaging doi: 10.2310/7290.2006.00001 – volume: 14 start-page: 235 year: 2008 ident: ref57/cit57 publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-2008-14211 – volume-title: Magnetism in Medicine: A Handbook year: 2007 ident: ref5/cit5 – volume: 18 start-page: 383 year: 2005 ident: ref62/cit62 publication-title: NMR Biomed. doi: 10.1002/nbm.970 – volume: 12 start-page: 6677 year: 2006 ident: ref18/cit18 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-06-0946 – volume: 27 start-page: 353 year: 1984 ident: ref19/cit19 publication-title: Microvasc. Res. doi: 10.1016/0026-2862(84)90065-7 – ident: ref33/cit33 – volume: 3 start-page: 427 year: 2006 ident: ref61/cit61 publication-title: Expert Rev. Med. Devices doi: 10.1586/17434440.3.4.427 – volume: 56 start-page: 249 year: 1998 ident: ref72/cit72 publication-title: J. Controlled Release doi: 10.1016/S0168-3659(98)00093-5 – volume: 241 start-page: 1662 year: 2004 ident: ref37/cit37 publication-title: Phys. Status Solidi B doi: 10.1002/pssb.200304692 – volume: 23 start-page: 1418 year: 2005 ident: ref66/cit66 publication-title: Nat. Biotechnol. doi: 10.1038/nbt1159 – ident: ref12/cit12 – volume: 152 start-page: 167 year: 1989 ident: ref32/cit32 publication-title: Am. J. Roentgenol. doi: 10.2214/ajr.152.1.167 – volume: 19 start-page: 491 year: 2006 ident: ref14/cit14 publication-title: J. Aerosol Med. doi: 10.1089/jam.2006.19.491 – volume: 311 start-page: 469 year: 2007 ident: ref42/cit42 publication-title: J. Colloid Interface Sci. doi: 10.1016/j.jcis.2007.03.023 – volume: 2 start-page: 495 year: 2007 ident: ref15/cit15 publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2007.217 – volume: 7 start-page: S24 year: 2007 ident: ref4/cit4 publication-title: Cancer Imaging doi: 10.1102/1470-7330.2007.9001 – volume: 334 start-page: 1121 year: 2005 ident: ref28/cit28 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.06.204 – volume: 22 start-page: 15 year: 2003 ident: ref50/cit50 publication-title: Orbit doi: 10.1076/orbi.22.1.15.14007 – volume: 194 start-page: 132 year: 1999 ident: ref11/cit11 publication-title: J. Magn. Magn. Mater. doi: 10.1016/S0304-8853(98)00584-8 – volume: 48 start-page: 1839 year: 2006 ident: ref16/cit16 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2006.06.069 – volume: 18 start-page: S2893 year: 2006 ident: ref21/cit21 publication-title: J. Phys. Condens. Matter doi: 10.1088/0953-8984/18/38/S24 – volume: 6 start-page: 913 year: 2004 ident: ref29/cit29 publication-title: J. Gene Med. doi: 10.1002/jgm.569 – volume: 89 start-page: 338 year: 2006 ident: ref60/cit60 publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfj027 – volume: 85 start-page: 699 year: 1978 ident: ref22/cit22 publication-title: Am. J. Ophthalmol. doi: 10.1016/S0002-9394(14)77108-9 – volume: 23 start-page: 6927 year: 2007 ident: ref46/cit46 publication-title: Langmuir doi: 10.1021/la070116+ – volume: 13 start-page: 245 year: 1996 ident: ref59/cit59 publication-title: J. Microencapsul. doi: 10.3109/02652049609026013 – volume: 311 start-page: 84 year: 2007 ident: ref41/cit41 publication-title: J. Magn. Magn. Mater. doi: 10.1016/j.jmmm.2006.10.1170 – volume: 329 start-page: 107 year: 2009 ident: ref40/cit40 publication-title: J. Colloid Interface Sci. doi: 10.1016/j.jcis.2008.09.071 – volume: 15 start-page: 1367 year: 2003 ident: ref45/cit45 publication-title: Chem. Mater. doi: 10.1021/cm020994n – volume: 10 start-page: 281 year: 2008 ident: ref38/cit38 publication-title: Biomed. Microdevices doi: 10.1007/s10544-007-9134-7 – volume: 293 start-page: 433 year: 2005 ident: ref71/cit71 publication-title: J. Magn. Magn. Mater. doi: 10.1016/j.jmmm.2005.02.037 – volume: 15 start-page: 321 year: 2004 ident: ref74/cit74 publication-title: J. Mater. Sci.: Mater. Med. – volume: 90 start-page: 1068 year: 1963 ident: ref47/cit47 publication-title: Am. J. Roentgenol. Radium Ther. Nucl. Med. – volume: 311 start-page: 347Z year: 2007 ident: ref25/cit25 publication-title: J. Magn. Magn. Mater. doi: 10.1016/j.jmmm.2006.10.1174 – volume: 12 start-page: 213 year: 2001 ident: ref49/cit49 publication-title: Bioconjugate Chem. doi: 10.1021/bc000091p – volume: 194 start-page: 76 year: 1999 ident: ref73/cit73 publication-title: J. Magn. Magn. Mater. doi: 10.1016/S0304-8853(98)00560-5 – volume: 57 start-page: 785 year: 2005 ident: ref58/cit58 publication-title: Neurosurgery doi: 10.1227/01.NEU.0000175731.25414.4c – volume: 11 start-page: 2319 year: 2001 ident: ref1/cit1 publication-title: Eur. Radiol. doi: 10.1007/s003300100908 – start-page: 1 volume-title: Nanotechnology in Biology and Medicine: Methods, Devices, and Applications year: 2007 ident: ref2/cit2 – volume: 27 start-page: 299 year: 2008 ident: ref7/cit7 publication-title: J. Magn. Reson. Imaging doi: 10.1002/jmri.21263 – start-page: 77 volume-title: Smart Nanoparticles in Nanomedicine: the MML Series year: 2006 ident: ref9/cit9 – volume: 82 start-page: 715 year: 2007 ident: ref51/cit51 publication-title: Arch. Soc. Esp. Oftalmol. – volume: 74 start-page: 32 year: 1997 ident: ref65/cit65 publication-title: Eur. J. Cell Biol. – volume: 24 start-page: 4529 year: 2003 ident: ref64/cit64 publication-title: Biomater. doi: 10.1016/S0142-9612(03)00348-X – volume: 5 start-page: S170 year: 1998 ident: ref48/cit48 publication-title: Acad. Radiol. doi: 10.1016/S1076-6332(98)80096-2 – volume: 3 start-page: 264 year: 1980 ident: ref13/cit13 publication-title: J. Pharmacobio-Dyn. doi: 10.1248/bpb1978.3.264 – volume: 52 start-page: 464 year: 1999 ident: ref55/cit55 publication-title: Appl. Microbiol. Biotechnol. doi: 10.1007/s002530051547 – volume: 29 start-page: 200 year: 1985 ident: ref10/cit10 publication-title: Ann. Radiol. – volume: 2 start-page: 2391 year: 2007 ident: ref27/cit27 publication-title: Nat. Protocols doi: 10.1038/nprot.2007.352 – volume: 11 start-page: 996 year: 2004 ident: ref63/cit63 publication-title: Acad. Radiol. doi: 10.1016/j.acra.2004.04.018 – volume: 68 start-page: 251 year: 1980 ident: ref54/cit54 publication-title: Int. Rev. Cytol. doi: 10.1016/S0074-7696(08)62312-8 – volume: 110 start-page: 164 year: 1987 ident: ref31/cit31 publication-title: J. Lab. Clin. Med. – ident: ref34/cit34 – volume: 59 start-page: 217 year: 1989 ident: ref53/cit53 publication-title: Br. J. Cancer doi: 10.1038/bjc.1989.44 – volume: 256 start-page: 89 year: 2001 ident: ref68/cit68 publication-title: J. Immunol. Methods doi: 10.1016/S0022-1759(01)00433-1 – volume-title: Synthesis, Functionalization and Surface Treatment of Nanoparticles year: 2003 ident: ref44/cit44 – volume: 97 start-page: 10Q905 year: 2005 ident: ref36/cit36 publication-title: J. Appl. Phys. doi: 10.1063/1.1850855 – start-page: 163 volume-title: Magnetic Cell Separation year: 2007 ident: ref75/cit75 doi: 10.1016/S0075-7535(06)32007-4 – volume: 292 start-page: 108 year: 2005 ident: ref24/cit24 publication-title: J. Magn. Magn. Mater. doi: 10.1016/j.jmmm.2004.10.103 – volume: 8 start-page: 214 year: 2006 ident: ref69/cit69 publication-title: Neoplasia doi: 10.1593/neo.05769 – volume: 21 start-page: 8858 year: 2005 ident: ref67/cit67 publication-title: Langmuir doi: 10.1021/la0503451 – volume: 321 start-page: 1356 year: 2009 ident: ref39/cit39 publication-title: J. Magn. Magn. Mater. doi: 10.1016/j.jmmm.2009.02.038 – ident: ref52/cit52 – volume: 1 start-page: 101 year: 1992 ident: ref56/cit56 publication-title: Bioelectromagnetics doi: 10.1002/bem.2250130710 – volume: 2 start-page: 307 year: 2007 ident: ref3/cit3 publication-title: Nanomed. doi: 10.2217/17435889.2.3.307 – volume: 14 start-page: 661 year: 2003 ident: ref23/cit23 publication-title: Nanotechnology doi: 10.1088/0957-4484/14/6/318 – volume: 6 start-page: 351 year: 2000 ident: ref8/cit8 publication-title: Nat. Med. doi: 10.1038/73219 |
SSID | ssj0024523 |
Score | 2.3978732 |
Snippet | Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1417 |
SubjectTerms | Biological Transport, Active Cell Line, Tumor Cell Survival - drug effects Cells, Cultured Drug Delivery Systems Endothelial Cells - drug effects Ferrosoferric Oxide - administration & dosage Ferrosoferric Oxide - pharmacokinetics Ferrosoferric Oxide - toxicity Humans Male Materials Testing Metal Nanoparticles - administration & dosage Metal Nanoparticles - chemistry Metal Nanoparticles - toxicity Metal Nanoparticles - ultrastructure Microscopy, Electron, Transmission Nanotechnology Particle Size Polyethylene Glycols - chemistry Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology Retinal Pigment Epithelium - cytology Retinal Pigment Epithelium - drug effects |
Title | Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery |
URI | http://dx.doi.org/10.1021/mp900083m https://www.ncbi.nlm.nih.gov/pubmed/19445482 https://www.proquest.com/docview/734069611 https://www.proquest.com/docview/754550252 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT9tAEB5RuPTSFkrbtAWNWoR6wJR9eL17REkRQqJCIkHcrN31GkUEO0psqemv767tkFblcR_Lj53xfKOZ7xuAPW5yroyJI-tzU8SNEZGMMxk5ro2TmUpYHtjI5z_F6YifXcfXa_D1kQ4-Jd_vpqoBCncvYIMKSUKFddy_XAnqxc0ONw8FWCSZ5Ev5oL8vDanHzv9NPY_gySavnLyGwZKd046T3B7WlTm0v_8Xa3zqkd_Aqw5X4nHrCJuw5oot2L9ohakXBzhc8azmB7iPFyvJ6sVbuOq7yQRH00rfOtRFhuMCr8bVrMRh-WtsPVLHMsdzfVMEziP6X7KvtbuROrysx1UgYKHHvziY1Tc4cJMw7rHYhtHJj2H_NOo2LkSacVFFlBKrM6JCM8bkhoVyyGqa-RqQ5pmwVEpLiKaJjtmROhLSJL7-VNpHsfCBTdg7WC_Kwn0ADKJARDMXM2q40E5RaiVVxCrjEVuierDrjyTtImaeNs1wStL7b9eDb8vTSm2nVx7WZkweMv1ybzptRToeMsLlkac-hEJfRBeurOdpwgL9VxDyhEkc2N80pj1433rL6kaKc1_20Y_PvdAneNm0oprpg8-wXs1qt-MRTWV2G4_-A6Cv7ak |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NT9wwELVaOLSXUmgL21I6qirUAwH8kcQ-VkvRtmUREruIW2Q7DlqxJKtNIrH99dhOlpSKftwniRN7Mm80894g9ImpjAmlwkDb2BQwpaKAhykPDJPK8FTENHNs5OFpNBiz75fhZSuT47gwdhGlvVPpi_idugA-uJkJjxdunqJVr4DiYFD_vNPVC_0oN4sIaMApZ0sVoV8vdRFIlw8j0B9gpQ8vx2vNnCK_MN9Vcr1fV2pf__xNs_H_Vv4SvWhRJnxpjsU6emLyDbR71shUL_Zg1LGuyj3YhbNOwHrxCl30zXQK41klrw3IPIVJDheTal7AqLidaIvbochgKK9yx4AE-4O2mXfbYAfn9aRydCywaBiO5vUVHJmpa_5YvEbj46-j_iBo5y8EkrKoCgjBWqZYuNKMyhR1yZGWJLUZIcnSSBPONcaSxDKkh-Iw4iq22aiQ1qcj6-aYvkEreZGbLQROIghLakJKFIukEYRoTgTWQln8Fose2rGfLmn9p0x8aZzg5P7b9dDn5aYlulUvd0M0po-Zfrw3nTWSHY8ZwXLnE-tQrkoic1PUZRJTRwaOMP6LSei44CQkPbTZHJruQYIxmwSSt_96oQ_o2WA0PElOvp3-eIee-yKV70vYRivVvDbvLdap1I4_5HfvhPYU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bT9swFLY2Jk17GezesbGjaUJ7IIBvif2I2lXsAqtEi3iLbMdBFSWpmkSi_PrZbtpuE7u8n8SO7ZPzHZ3zfUboA9M5k1rzyLjYFDGt40jwTESWKW1FJhOaezbyyWl8PGJfLvhFmyh6LoybROXeVIUivvfqaZa3CgP44HoqA2a4vo8ecC_95qFQ92ytrcfDdW4OFdBIUMGWSkI_P-qjkKl-jUJ_gJYhxPQ30ffV5EJnydV-U-t9c_ubbuP_z34LPW7RJhwtjscTdM8WT9HuYCFXPd-D4Zp9Ve3BLgzWQtbzZ-i8aycTGE1rdWVBFRmMCzgf17MShuXN2Dj8DmUOJ-qy8ExIcD9ql4G3jXZw1oxrT8sCh4qhN2suoWcnvglk_hyN-p-G3eOovYchUpTFdUQINirD0pdodK6pT5KMIpnLDEmexYYIYTBWJFGcHsrDWOjEZaVSOd-Onbtj-gJtFGVhXyHwUkFYUcsp0SxWVhJiBJHYSO1wXCI7aMctX9r6UZWGEjnB6WrtOujjcuNS06qY-8s0JneZvl-ZThfSHXcZwXL3U-dYvlqiCls2VZpQTwqOMf6LCfeccMJJB71cHJz1QJIxlwyS1__6oHfo4aDXT799Pv26jR6FWlVoT3iDNupZY986yFPrnXDOfwD2uPiO |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell+uptake+and+in+vitro+toxicity+of+magnetic+nanoparticles+suitable+for+drug+delivery&rft.jtitle=Molecular+pharmaceutics&rft.au=H%C3%A4feli%2C+Urs+O&rft.au=Riffle%2C+Judy+S&rft.au=Harris-Shekhawat%2C+Linda&rft.au=Carmichael-Baranauskas%2C+Anita&rft.date=2009-10-05&rft.issn=1543-8384&rft.volume=6&rft.issue=5&rft.spage=1417&rft_id=info:doi/10.1021%2Fmp900083m&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1543-8384&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1543-8384&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1543-8384&client=summon |